Form 483

Drug Depot, Inc., dba APS Pharmacy Form 483, 2022-06-17

FDA issued a Form 483 to Drug Depot, Inc., dba APS Pharmacy on 2022-06-17 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Drug Depot, Inc., dba APS Pharmacy · Palm Harbor, United States · Issued June 17, 2022

Overview

  • 3 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Jun 2022
FDCA 501(a)(2)(A)

Cleanliness, ISO-classified areas

Cited by Saundrea A Munroe, Martrice A Packer, Jessica M Simpson

17 Jun 2022
FDCA 501(a)(2)(A)

Disruption of airflow from personnel movement

Cited by Saundrea A Munroe, Martrice A Packer, Jessica M Simpson

17 Jun 2022
FDCA 501(a)(2)(A)

First pass air blockage, open unit with sterile product

Cited by Saundrea A Munroe, Martrice A Packer, Jessica M Simpson

Inspected site

DDDrug Depot, Inc., dba APS PharmacyPalm Harbor, United States

Inspection team

MAMartrice A Packer

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere